Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
After gaining Food and Drug Administration approval nearly a year ago, patients can finally walk into a pharmacy and get their prescription for VIVUS' (NASDAQ: VVUS ) weight loss drug Qsymia.
The drug has been on the market in the interim, but it was only available through mail-order pharmacies. The FDA required the extra regulation because Qsymia can cause birth defects if pregnant women take the drug.
http://www.fool.com/investing/general/2013/07/02/obesity-drug-hits-pharmacies.aspx
The drug has been on the market in the interim, but it was only available through mail-order pharmacies. The FDA required the extra regulation because Qsymia can cause birth defects if pregnant women take the drug.
http://www.fool.com/investing/general/2013/07/02/obesity-drug-hits-pharmacies.aspx